ISSN 1662-4009 (online)

Previous issue | Volume 17 | ESPEYB17 | Next issue

Yearbook of Paediatric Endocrinology 2020

ey0017.2-1 | Neonatal Hypoglycaemia | ESPEYB17

2.1. Clinical and genetic characterization of 153 patients with persistent or transient congenital hyperinsulinism

JME Mannisto , M Maria , J Raivo , T Kuulasmaa , T Otonkoski , H Huopio , Laakso

To read the full abstract: J Clin Endocrinol Metab. 2020 Apr 1;105(4). PMID: 32170320In congenital hyperinsulinism (CHI) there is dysregulation of insulin secretion that leads to persistent hypoglycaemia. Mutations in the ABCC8/KCNJ11 genes which encode the pancreatic KATP channels proteins (SUR1/KIR6.2 respectively) are the most common causes of CHI. Mutations ...

ey0017.2-2 | Neonatal Hypoglycaemia | ESPEYB17

2.2. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multi-centre study in the United Kingdom

SC Chen , A Dastamani , D Pintus , D Yau , S Aftab , L Bath , C Swinburne , L Hunter , A Giardini , G Christov , S Senniappan , I Banerjee , MG Shaikh , P Shah

To read the full abstract: Clin Endocrinol (Oxf). 2019 Dec;91(6):770–775. PMID: 31520536Diazoxide is the first line treatment for patients with hyperinsulinaemic hypoglycaemia (HH). The vast majority of patients tolerate diazoxide well without any major complications. However, diazoxide is known to cause several side effects including hypertrichosis, neutropaenia, thrombocytop...

ey0017.2-3 | Neonatal Hypoglycaemia | ESPEYB17

2.3. Lower versus traditional treatment threshold for neonatal hypoglycemia

AAMW van Kempen , PF Eskes , DHGM1 Nuytemans , JH van der Lee , LM Dijksman , NR van Veenendaal , FJPCM van der Hulst , RMJ Moonen , LJI Zimmermann , EP van’t Verlaat , Baal M van Dongen-van , BA Semmekrot , HG Stas , RHT van Beek , JJ Vlietman , PH Dijk , JUM Termote , RCJ de Jonge , AC de Mol , MWA Huysman , JH Kok , M Offringa , N; HypoEXIT Study Group Boluyt

To read the full abstract: N Engl J Med. 2020 Feb 6;382(6):534–544. PMID: 32023373Neonatal hypoglycaemia is one of the most common biochemical findings in the newborn period and is an important cause of brain injury. However, despite being so common there is no consensus regarding the glucose threshold concentration at which treatment for asymptomatic neonatal hypoglycemia sho...

ey0017.2-4 | Neonatal Hypoglycaemia | ESPEYB17

2.4. Targeting glucose control in preterm infants: Pilot studies of continuous glucose monitoring

L Thomson , D Elleri , S Bond , J Howlett , DB Dunger , K Beardsall

To read the full abstract: Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F353–F359. PMID:30232094.In preterm and in the very low birthweight infants, hyperglycaemia is associated with increased risks of mortality, brain injury, retinopathy of prematurity and worse neurodevelopmental outcomes (1). Treatment of hyperglycaemia with continuous insulin infusion leads to increas...

ey0017.2-5 | Neonatal Hypoglycaemia | ESPEYB17

2.5. Glucose profiles in healthy term infants in the first 5 days: the glucose in well babies (GLOW) study

DJ Harris , PJ Weston , GD Gamble , JE Harding

To read the full abstract: J Pediatr. 2020 May 4. pii: S0022-3476(20)30295-X. doi: 10.1016/j.jpeds.2020.02.079. [Epub ahead of print]. PMID:32381469Understanding the typical patterns of blood glucose profiles in healthy term infants is needed to inform guidelines for the management of hypoglycaemia. Typically blood glucose levels fall rapidly after birth (30–90 min), then stabiliz...